BioIVT Supports COVID-19 Drug, Diagnostic and Vaccine Researchers by Expanding its Inventory of Patient Plasma, Serum and Saliva Specimens
BioIVT currently has more than 5,000 COVID-19 specimens available and ready to ship.
- BioIVT currently has more than 5,000 COVID-19 specimens available and ready to ship.
- BioIVT is adding new COVID-19 specimens to its inventory every week.
- They include nasopharyngeal (NP) swabs, saliva, and blood-derived and immune cells from acute, antibody positive, and recovered COVID-19 donors.
- Specimens are collected from fully consented donors in hospitals, clinics and blood donation centers in the US, EU and UK.